Setting the Stage for a Multimarker-Based Heart Failure Prevention Trial?
Publication
, Journal Article
Ahmad, T; Felker, GM
Published in: JACC Heart Fail
March 2021
Duke Scholars
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
March 2021
Volume
9
Issue
3
Start / End Page
224 / 225
Location
United States
Related Subject Headings
- Sodium-Glucose Transporter 2 Inhibitors
- Humans
- Heart Failure
- Diabetes Mellitus, Type 2
- Cardiovascular Diseases
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Ahmad, T., & Felker, G. M. (2021). Setting the Stage for a Multimarker-Based Heart Failure Prevention Trial? JACC Heart Fail, 9(3), 224–225. https://doi.org/10.1016/j.jchf.2021.01.001
Ahmad, Tariq, and G Michael Felker. “Setting the Stage for a Multimarker-Based Heart Failure Prevention Trial?” JACC Heart Fail 9, no. 3 (March 2021): 224–25. https://doi.org/10.1016/j.jchf.2021.01.001.
Ahmad T, Felker GM. Setting the Stage for a Multimarker-Based Heart Failure Prevention Trial? JACC Heart Fail. 2021 Mar;9(3):224–5.
Ahmad, Tariq, and G. Michael Felker. “Setting the Stage for a Multimarker-Based Heart Failure Prevention Trial?” JACC Heart Fail, vol. 9, no. 3, Mar. 2021, pp. 224–25. Pubmed, doi:10.1016/j.jchf.2021.01.001.
Ahmad T, Felker GM. Setting the Stage for a Multimarker-Based Heart Failure Prevention Trial? JACC Heart Fail. 2021 Mar;9(3):224–225.
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
March 2021
Volume
9
Issue
3
Start / End Page
224 / 225
Location
United States
Related Subject Headings
- Sodium-Glucose Transporter 2 Inhibitors
- Humans
- Heart Failure
- Diabetes Mellitus, Type 2
- Cardiovascular Diseases
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology